| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPHW)
RVPHW Technical Analysis
5
| As on 10th Dec 2025 RVPHW SHARE Price closed @ 0.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.08 & Strong Sell for SHORT-TERM with Stoploss of 0.19 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RVPHWSHARE Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | -0.01 | -100.00 |
| Low | 0.00 | 1 Week | -0.01 | -100.00 |
| Close | 0.00 | 1 Month | -0.04 | -100.00 |
| Volume | 267765 | 1 Year | -0.22 | -100.00 |
| 52 Week High 0.50 | 52 Week Low 0.00 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 183.78 | -0.64% |
| MNTS | 0.89 | 17.11% |
| IRBT | 5.24 | 48.44% |
| LMDX | 0.02 | 0.00% |
| AKTS | 0.04 | 0.00% |
| PLUG | 2.26 | 2.26% |
| ONDS | 8.32 | -9.86% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RVPHW Daily Charts |
RVPHW Intraday Charts |
Whats New @ Bazaartrend |
RVPHW Free Analysis |
|
|
RVPHW Important Levels Intraday
| RESISTANCE | 0.02 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| SUPPORT | -0.01 |
| SUPPORT | -0.01 |
| SUPPORT | -0.01 |
| SUPPORT | -0.02 |
RVPHW Forecast December 2025
| 4th UP Forecast | 0.44 |
| 3rd UP Forecast | 0.3 |
| 2nd UP Forecast | 0.21 |
| 1st UP Forecast | 0.13 |
| 1st DOWN Forecast | -0.13 |
| 2nd DOWN Forecast | -0.21 |
| 3rd DOWN Forecast | -0.3 |
| 4th DOWN Forecast | -0.44 |
RVPHW Weekly Forecast
| 4th UP Forecast | 0.73 |
| 3rd UP Forecast | 0.50 |
| 2nd UP Forecast | 0.35 |
| 1st UP Forecast | 0.21 |
| 1st DOWN Forecast | -0.21 |
| 2nd DOWN Forecast | -0.35 |
| 3rd DOWN Forecast | -0.50 |
| 4th DOWN Forecast | -0.73 |
RVPHW Forecast2025
| 4th UP Forecast | 1.5 |
| 3rd UP Forecast | 1.02 |
| 2nd UP Forecast | 0.72 |
| 1st UP Forecast | 0.43 |
| 1st DOWN Forecast | -0.43 |
| 2nd DOWN Forecast | -0.72 |
| 3rd DOWN Forecast | -1.02 |
| 4th DOWN Forecast | -1.5 |
Reviva Pharmaceuticals Holdings Inc ( NASDAQ USA Symbol : RVPHW )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
RVPHW Other Details
| Segment | EQ | |
| Market Capital | 85814048.00 | |
| Sector | ||
| Industry | ||
| Offical website | > echo $website ; ?> | |
RVPHW Address
![]() |
||
RVPHW Latest News
RVPHW Business Profile
Reviva Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops therapies to address unmet medical needs in the areas of central nervous system, cardiovascular, metabolic, and inflammatory diseases. Its lead product candidate is RP5063 for the treatment of schizophrenia, bipolar disorder, and major depressive disorder, as well as for treating pulmonary arterial hypertension and idiopathic pulmonary fibrosis. The company is based in Cupertino, California. Address: 19925 Stevens Creek Boulevard, Cupertino, CA, United States, 95014
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

